Ginsenoside F1 Protects the Brain against Amyloid Beta-Induced Toxicity by Regulating IDE and NEP
Ginsenoside F1, the metabolite of Rg1, is one of the most important constituents of <i>Panax ginseng</i>. Although the effects of ginsenosides on amyloid beta (Aβ) aggregation in the brain are known, the role of ginsenoside F1 remains unclear. Here, we investigated the protective effect...
Main Authors: | Yee-Jin Yun, Bong-Hwan Park, Jingang Hou, Jung-Pyo Oh, Jin-Hee Han, Sun-Chang Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/1/58 |
Similar Items
-
Comparative studies for amyloid beta degradation: “Neprilysin vs insulysin”, “monomeric vs aggregate”, and “whole Aβ40 vs its peptide fragments”
by: Dai Kato, et al.
Published: (2022-07-01) -
Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
by: Robert eMarr, et al.
Published: (2014-08-01) -
Intranasal neprilysin rapidly eliminates amyloid-beta plaques, but causes plaque compensations: the explanation why the amyloid-beta cascade may fail?
by: Christian Humpel
Published: (2022-01-01) -
Tripchlorolide attenuates β-amyloid generation by inducing NEP activity in N2a/APP695 cells
by: Zeng Yuqi, et al.
Published: (2021-07-01) -
The immuneregulator role of neprilysin (NEP) in invertebrates
by: E Ottaviani, et al.
Published: (2012-11-01)